1085801

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy — FEI 3014877770

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
April 5, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bristol, TN (United States)

Citations

IDCFRDescription
18936FDCA 501(a)(2)(A)Non-microbial contamination, production area
18938FDCA 501(a)(2)(A)Hazardous drugs, prevention of cross-contamination
18955FDCA 501(a)(2)(A)Ceiling tiles, cleanroom
18956FDCA 501(a)(2)(A)Cleanliness, ISO-classified areas